Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Orikami logo — Orikami is a Dutch MedTech organization specialized in apply...

Orikami

Orikami is a Dutch MedTech organization specialized in applying data science and developing digital biomarkers.

Founded 2011 The Netherlands The Netherlands 18 employees Seed Total: $600.00K Analytics, Health Care +2

General Information

Company Name Orikami
Founded Year 2011
Location The Netherlands The Netherlands
Founders / Decision Makers
Team member
Employees 18
Industries Analytics, Health Care, Health and Wellness +1
Funding Stage Seed
Business Model B2B, DaaS, B2D
Revenue Model Service Fee, Consulting Fee, Data Monetization
Offices as of Oct 2026
Nijmegen, The Netherlands
Social

BounceWatch is an independent company data service, not affiliated with Orikami. To contact Orikami, visit orikami.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Orikami compare?

A PDF of Orikami and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Orikami soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Major Customer Win Oct 09, 2026

Orikami secured a deal to provide its KRANE™ platform as the central infrastructure for the Care is Coming Home consortium, which includes Erasmus MC and University of Twente.

Get alerts when Orikami shows new signals

About Orikami

Orikami is a pioneering Dutch MedTech organization founded in 2011, specializing in applied data science to enhance personalized healthcare. The company focuses on developing and implementing digital biomarkers—objective, quantifiable data collected via digital devices—to improve outcomes for individuals with chronic diseases. Their mission is ambitious: to positively impact 100 million lives by 2030.

Operating at the intersection of Analytics, Health Care, and Medical Devices, Orikami leverages advanced analytics, machine learning, and artificial intelligence to harness underutilized health data. Their approach promises improved health outcomes and quality of life while maintaining affordability.

Headquartered in The Netherlands, Orikami was propelled by a €600.00K Seed Round led by Healthy.Capital on 09 October 2019. This funding supported Orikami's trailblazing work in the burgeoning MedTech landscape, positioning it as a promising entity for investors focused on tech-driven healthcare solutions.

Business keywords: MedTech, Digital Biomarkers, Personalized Healthcare, Chronic Diseases, Advanced Analytics, Patient Data, Wearable Technology, Healthcare Analytics, ISO27001, ISO13485, Healthcare Consultancy, Health Data Utilization

Services & Products

Development of Digital Biomarkers
Integration of Healthcare Data
Medical Algorithm Development
Scalable Infrastructure for SaMD

Target Customers

Medical Researchers MedTech Developers Healthcare Organizations Clinical Research Teams

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round €600.00K 1
Healthy.Capital
Healthy.Capital
09 Oct 2019

Orikami Alternatives & Competitors

View All Alternatives
Orikami vs
OptiChroniX
OptiChroniX Switzerland

Cognitive Care and Aging Well for Billions

Pre-Seed
4 employees
Digital Health, Health Care
Orikami vs
inContAlert
inContAlert Germany

Know your body. Own your life.

Seed
13 employees
AI, Digital Health
Orikami vs
Mode Sensors
Mode Sensors Norway

Next-Generation Wearable Technology for Healthcare

Grant
14 employees
Digital Health, Health Care
View all alternatives

FAQ About Orikami

Orikami is a Dutch MedTech organization specialized in applying data science and developing digital biomarkers.
Orikami was founded in 2011.
Orikami is headquartered in The Netherlands. As of Oct 2026, it also has offices in Nijmegen, The Netherlands.
Orikami operates in Analytics, Health Care, Health and Wellness and Medical Devices. Its work centres on MedTech, Digital Biomarkers, Personalized Healthcare and Chronic Diseases. Its customers include Medical Researchers, MedTech Developers and Healthcare Organizations.
Orikami has a B2B, DaaS and B2D business model. Its revenue comes from Service Fee, Consulting Fee and Data Monetization.
Orikami has approximately 18 employees.
Orikami has completed 1 funding round, raising a total of $600.00K. The latest funding stage is Seed.
Orikami offers: Development of Digital Biomarkers, Integration of Healthcare Data, Medical Algorithm Development, Scalable Infrastructure for SaMD.
Top alternatives and competitors to Orikami include OptiChroniX, inContAlert, Mode Sensors, Bloomer Tech, BIOSerenity. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Orikami and OptiChroniX are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Orikami, https://bouncewatch.com/company/orikaminl, updated 8 October 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes